Back

Long-term prognosis and predictors of death in chronic Chagas cardiomyopathy in women and men.

31 August 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease in women (3) Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Antonio De Padua Mansur

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

7 More presentations in this session

Presentation thumbnail
Sex disparities in bystander defibrillation for out-of-hospital cardiac arrest
Doctor E. Paratz (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Sex-specific associations between remnant cholesterol and cardiovascular risk in patients undergoing percutaneous coronary intervention: a 5-year large-sample study from the real world
Doctor K. Yan (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Beyond the change: exploring age of menopause, lifestyle, and cardiovascular risk in women
Ms A. Pant (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Novel deep learning algorithm demonstrates strong performance for detection and quantification of breast arterial calcification and associates with cardiovascular disease
Doctor V. Goel (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Impact of sex and age on culprit plaque type of acute coronary syndrome in Japanese patients from TACTICS registry
Doctor T. Shinke (Tokyo, JP)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular disease in women (3)

The Event

Event poster

ESC Congress 2024

31 August 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Chagas disease diagnosis and clinical outcomes in patients hospitalized due to heart failure in the United States
thumbnail
Congress Presentation
Does gender really affect the prognosis of heart failure patients with reduced ejection fraction?
thumbnail
Congress Presentation
Mortality and predictors of death in women and men with congestive heart failure due to ischemic and nonischemic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources